← Every applicant
Viwit Pharm FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GADOTERATE MEGLUMINENew drugAug 10, 2026SOLUTION, INTRAVENOUS |
| GADOBUTROLNew drugJun 11, 2026SOLUTION, INTRAVENOUS |
| LIDOCAINE HYDROCHLORIDENew drugMar 19, 2026INJECTABLE, INJECTION |
| VARENICLINE TARTRATENew drugMay 6, 2025TABLET, ORAL |
| NITROGLYCERINNew drugOct 15, 2024TABLET, SUBLINGUAL |
| PROCHLORPERAZINE EDISYLATENew drugSep 28, 2021INJECTABLE, INJECTION |